Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 41 non-cytoplasmic 42 62 transmembrane 63 93 cytoplasmic 94 118 transmembrane 119 144 non-cytoplasmic 145 164 transmembrane 165 175 cytoplasmic 176 196 transmembrane 197 215 non-cytoplasmic 216 241 transmembrane 242 252 cytoplasmic 253 276 transmembrane 277 311 non-cytoplasmic 312 312 cytoplasmic 313 337 transmembrane 338 356 cytoplasmic 357 382 transmembrane 383 383 cytoplasmic 384 387 non-cytoplasmic 388 388 cytoplasmic 389 406 transmembrane 407 424 cytoplasmic 425 425 non-cytoplasmic 426 450 transmembrane 451 452 non-cytoplasmic
Input: >5207779 FitnessBrowser__PV4:5207779 MSAKDLGHFSSRIGFIMAAAGSAVGVGNIWGFPTQAATHGGGAFLLVYLVLIFLLGYPML VAELMIGRHGQTNPADAMAKLGSSKLSRNLGKTIGFASIITATLICTFYSILSGWFVSFT LAPIARLVGMQDIALWLTSFSLERNLLFTLIFILMVVLVIRQGVQQGIEAWSKRLMPLLL AILILGVAYILTQPGASQGLNALLVPDFGRIWEPQVLIGALGQTFFSLTVGTGAMMVYGA YLNRQENLAKLTAYVTLTDTSVAFLAALMIIPAMYVAQHNGVQIFAADGSLLNADTLVFT VLPALFDSLGGLAGQLIAIVFFILMTIAGLTSAISIVEVPTSYMVEKTEIQRHSATYLVG GGIALLATIMVFNFDALFALVITLTTERAQPFIALGIALYTGWVWHRNSLLKAIAAQEGA KLDGLFWRIWPVYVKYVCPVLILAIILQLLTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server